약물과민반응이 의심되는 한국 소아에서 약물유발검사 결과
Outcomes of drug provocation tests in Korean children with suspected drug hypersensitivity reaction
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: Drug provocation tests (DPT) are the gold standard for confirming the diagnosis of drug hypersensitivity reactions (DHRs). However, there are little studies of DPT in children. The purpose of this study was to evaluate DPT results and safety as diagnostic methods of DHR in Korean children. Methods: We reviewed the medical records of 39 children under 18 years of age with a suspected DHR and performed DPT between January 2010 and May 2016 at Asan Medical Center. Results: Total 110 DPT were performed in 39 children (20 boys and 19 girls) with a history of DHR. Clinical presentation of DHR included skin rash (n=7), pruritus (n=3), urticaria (n=18), angioedema (n=19), dyspnea (n=5), hoarseness (n=1), hypothermia (n=1), and anaphylaxis (n=5). The median age at the time of DPT was 9 years. Positive DPT were observed in 21 of 39 children (53.8%) and 28 of 110 cases (25.5%). Drugs causing positive reactions were acetaminophen in 50% (9 of 18), nonsteroidal anti-inflammatory drugs in 29.2% (14 of 48), cephalosporin in 9.1% (1 of 11), trimethoprim/sulfamethoxazole in 50% (1 of 2), local anesthetics in 10% (1 of 10), and others (levodropropizine and idursulfase) in 15.4% (2 of 13). There was no statistical difference between children who had positive and negative results in sex, age, personal and parental history of allergic disease, eosinophil count, or total IgE level. Children with positive DPT did not develop anaphylaxis during the DPT procedure. Conclusion: Drug provocation test is safe, and it can be considered in children with suspected DHRs.
Abstract
Purpose: Drug provocation tests (DPT) are the gold standard for confirming the diagnosis of drug hypersensitivity reactions (DHRs). However, there are little studies of DPT in children. The purpose of this study was to evaluate DPT results and safety as diagnostic methods of DHR in Korean children. Methods: We reviewed the medical records of 39 children under 18 years of age with a suspected DHR and performed DPT between January 2010 and May 2016 at Asan Medical Center. Results: Total 110 DPT were performed in 39 children (20 boys and 19 girls) with a history of DHR. Clinical presentation of DHR included skin rash (n=7), pruritus (n=3), urticaria (n=18), angioedema (n=19), dyspnea (n=5), hoarseness (n=1), hypothermia (n=1), and anaphylaxis (n=5). The median age at the time of DPT was 9 years. Positive DPT were observed in 21 of 39 children (53.8%) and 28 of 110 cases (25.5%). Drugs causing positive reactions were acetaminophen in 50% (9 of 18), nonsteroidal anti-inflammatory drugs in 29.2% (14 of 48), cephalosporin in 9.1% (1 of 11), trimethoprim/sulfamethoxazole in 50% (1 of 2), local anesthetics in 10% (1 of 10), and others (levodropropizine and idursulfase) in 15.4% (2 of 13). There was no statistical difference between children who had positive and negative results in sex, age, personal and parental history of allergic disease, eosinophil count, or total IgE level. Children with positive DPT did not develop anaphylaxis during the DPT procedure. Conclusion: Drug provocation test is safe, and it can be considered in children with suspected DHRs.
참고문헌 (16)
- Johansson SG, "Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003", J Allergy Clin Immunol, 113, pp.832~836 (2004)[DOI]
- Khan DA, "Drug allergy", J Allergy Clin Immunol, 125(2 Suppl 2), pp.S126~S137 (2010)[DOI]
- Aberer W, "Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations", Allergy, 58, pp.854~863 (2003)[DOI]
- Demoly P, "Epidemiology of drug allergy", Curr Opin Allergy Clin Immunol, 1, pp.305~310 (2001)[DOI]
- Seitz CS, "Diagnosis of drug hypersensitivity in children and adolescents: discrepancy between physician-based assessment and results of testing", Pediatr Allergy Immunol, 22, pp.405~410 (2011)[DOI]
- Vezir E, "The evaluation of drug provocation tests in pediatric allergy clinic: a single center experience", Allergy Asthma Proc, 35, pp.156~162 (2014)[DOI]
- Aun MV, "Outcomes and safety of drug provocation tests", Allergy Asthma Proc, 32, pp.301~306 (2011)[DOI]
- Messaad D, "Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction", Ann Intern Med, 140, pp.1001~1006 (2004)[DOI]
- Hye Ran Na, "Usefulness of drug provocation tests in children with a history of adverse drug reaction", Clinical and Experimental Pediatrics, 54(7), pp.304~309 (2011), 대한소아청소년과학회
- Choi J, "Evaluation of drug provocation tests in Korean children: a single center experience", Asian Pac J Allergy Immunol, 34, pp.130~136 (2016)
- Simons FE, "World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base", Int Arch Allergy Immunol, 162, pp.193~204 (2013)[DOI]
- Simons FE, "International consensus on (ICON) anaphylaxis", World Allergy Organ J, 7, pp.9~ (2014)[DOI]
- Mirakian R, "BSACI guidelines for the management of drug allergy", Clin Exp Allergy, 39, pp.43~61 (2009)[DOI]
- Rubio M, "Results of drug hypersensitivity evaluations in a large group of children and adults", Clin Exp Allergy, 42, pp.123~130 (2012)[DOI]
- Indradat S, "Provocation proven drug allergy in Thai children with adverse drug reactions", Asian Pac J Allergy Immunol, 34, pp.59~64 (2016)
- 박근미, "소아에서 리도카인에 의한 지연성 두드러기 1예", Allergy Asthma & Respiratory Disease, 2(4), pp.298~301 (2014), 대한 소아알레르기 호흡기학회
